Certified by Founder Lodge
CrossBridge Bio
United States - Houston, Texas
START UP
1 Disclosed Funding Rounds $10,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
CrossBridge Bio is a biotechnology company focused on developing innovative ADC therapeutics using our proprietary stable dual-linker payload technology.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 05 ,2024 | Unknown | $10,000,000 |
Alexandria Real Estate Equities, Inc.
Portal Innovations, LLC
CE Ventures (CEIIF)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
